论文部分内容阅读
目的探究分析脑脊液分流术治疗原发性颅内肿瘤的效果。方法选取2014年12月至2016年1月原发性颅内肿瘤患者82例,按数字表法分为观察组(41例)与对照组(41例),观察组行脑脊液分流术治疗,对照组行基本手术治疗,观察比较两组患者术后5年内的生存情况及疗效。结果观察组术后1~5年的生存率分别为97.56%、90.24%、80.49%、70.73%、63.41%,总有效率为80.49%,均明显高于对照组术后1~5年的生存率(70.73%、63.41%、53.66%、43.90%、39.02%)及总有效率(48.78%),差异有统计学意义(P<0.05)。结论脑脊液分流术治疗原发性颅内肿瘤的效果更明显,能够有效减轻患者相关临床症状,显著改善患者预后。
Objective To investigate the effect of cerebrospinal fluid shunt on the treatment of primary intracranial tumors. Methods Totally 82 patients with primary intracranial tumors from December 2014 to January 2016 were divided into observation group (41 cases) and control group (41 cases) according to the digital table method. The observation group was treated with cerebrospinal fluid shunt Group basic surgical treatment, observation and comparison of two groups of patients after 5 years of survival and efficacy. Results The survival rates of the observation group from 1 year to 5 years after operation were 97.56%, 90.24%, 80.49%, 70.73% and 63.41%, respectively, with a total effective rate of 80.49%, which were significantly higher than those in the control group after 1 to 5 years (70.73%, 63.41%, 53.66%, 43.90%, 39.02%) and total effective rate (48.78%), the difference was statistically significant (P <0.05). Conclusion Cerebrospinal fluid shunt is more effective in treating primary intracranial tumors, which can effectively reduce the clinical symptoms and significantly improve the prognosis of patients.